Earum Pharmaceuticals Ltd.

View in App
0.98 0.00

08 December 2023, 10:59:00 AM
Volume: 292,436

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.earumpharma.com
Market Cap 24.22 Cr.
Enterprise Value(EV) 32.93 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.06 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 17.46 Trailing Twelve Months Ending 2023-06
Industry PE 38.89 Trailing Twelve Months Ending 2023-06
Book Value / Share 2.25 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.44 Calculated using Price: 0.98
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 24.71 Cr. 247,111,618 Shares
FaceValue 2
About Earum Pharmaceuticals Ltd.
The company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. Apart from pharmaceutical formulation products, it also deals in trading of active pharmaceutical ingredients (API's) such as Levofloxacin Hemihdrate IP, Albendazol IP, Amoxicillin Trihydrate IP etc.

Earum Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Earum Pharmaceuticals Ltd. Performance

View details >>
1 Day
1 Week
-2.97%
1 Month
-13.27%
3 Month
-2.97%
6 Month
-52.88%
1 Year
-55.66%
2 Year
-91.33%
5 Year
10 Year

Earum Pharmaceuticals Ltd. Fundamental Ratios

View details >>
8 years 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.15 11.05 30.94 32.17 17.83 0.61 14.24 11.18
Return on Capital Employed (%) 17.10 21.97 24.94 23.99 17.40 4.23 12.34 11.66
Return on Assets (%) 1.11 1.61 5.98 7.77 6.11 0.28 7.85 6.91

Earum Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 1 2 5 6 14 15 17 19
Non Curr. Liab. 0 1 2 3 1 2 0 0
Curr. Liab. 7 9 13 15 20 11 12 10
Minority Int.
Equity & Liab. 9 11 20 23 36 28 29 29
Non Curr. Assets 0 0 0 0 4 1 1 0
Curr. Assets 9 11 19 23 32 27 28 28
Misc. Exp. not W/O
Total Assets 9 11 20 23 36 28 29 29

Earum Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 9 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 19 23 35 51 55 41 21 14 12
Other Income 0 0 0 0 2 9 8 2 2
Total Income 19 24 36 51 57 50 29 16 14
Total Expenditure -18 -23 -34 -47 -54 -49 -25 -13 -11
PBIDT 1 1 2 3 4 1 3 3 3
Interest 0 -1 -1 -1 -1 -1 0 0 -1
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 -1 -1 0 -1 -1 -1
Exceptional Items
PAT 0 0 1 2 2 0 2 2 1
Adjusted EPS 0 0 0 0 0 0 0 0

Earum Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 8 years 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -7 0 -3 -7 3 0
Cash Fr. Inv. 0 0 0 0 -3 3 0
Cash Fr. Finan. 1 0 7 1 7 3 -3 0
Net Change 0 0 0 0 0 -1 0 0
Cash & Cash Eqvt 0 0 0 0 0 -1 0 0

Earum Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 70.04 70.04 50.21 37.57 0.00 0.00 0.00 0.00 0.00
Public 29.96 29.96 49.79 62.43 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Earum Pharmaceuticals Ltd. Announcements

View details >>
Fri, 13 Oct 2023
Reg. 34 (1) Annual Report.
Kindly find the attached Annual Report of the Company.
Tue, 10 Oct 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Kindly find attached compliance certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulations 2018.
Sat, 30 Sep 2023
Closure of Trading Window
Kindly find the attached intimation for closure of trading window.

Earum Pharmaceuticals Ltd. Technical Scans

View details >>
Thu, 07 Dec 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Earum Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,457.55 1,244.50 +0.4%
Divi's Laboratories Ltd. 99,108.71 3,707.15 -0.7%
Cipla Ltd. 98,730.88 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. 96,478.08 5,762.50 -0.4%
Mankind Pharma Ltd. 80,033.56 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. 78,513.61 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. 71,120.92 2,064.00 -1.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 74.42 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-09 28.59 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.95 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 62.44 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 112.57 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.31 2,064.00 -1.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-09 3.98 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 9.50 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.08 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.60 2,064.00 -1.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,064.00 -1.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,064.00 -1.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,064.00 -1.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,064.00 -1.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,244.50 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,707.15 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,216.55 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,762.50 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,988.45 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,450.00 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,064.00 -1.7%

Earum Pharmaceuticals Ltd. FAQ's

What is Earum Pharmaceutical share price?
Can I buy Earum Pharmaceutical shares now?
What is the Market Cap of Earum Pharmaceutical?
What are the key metrics to analyse Earum Pharmaceutical?
What is the 52 Week High and Low of Earum Pharmaceutical?
What is the trend of Earum Pharmaceutical share price?